Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti - podcast episode cover

Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti

Aug 10, 202237 minSeason 1Ep. 22
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

This is part 2 or our 3 part series on microdosing that explore the science, history, and clinical applications. In part 1, we interviewed psychedelic researcher James Fadiman about the fundamentals of microdosing. 

In part 2, we wanted to understand the placebo effect. In particular, is it the microdose that makes people feel better or it is a placebo effect? We interviewed Balázs Szigeti PhD, who is a researcher associate at the Centre for Psychedelic Research at Imperial College London. His team conducted the largest placebo-controlled microdosing study in 2020. Balázs unpacks the study and their findings in the episode.

Credits

Created by Greg Kubin and Matias Serebrinsky
Host:  Greg Kubin and Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank

Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love

Additional Music:
Distant Daze by Zack Frank
Zone Out by Daniel Fridell

Links to topics discussed in this episode:

Self-blinding citizen science to explore psychedelic microdosing (Szigeti et al., 2021)
Centre for Psychedelic Research - Imperial College London
Statistical and clinical significance


For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Microdosing (part 2): Placebo is a hell of a drug with Balázs Szigeti | Business Trip podcast - Listen or read transcript on Metacast